Cardiomyopathy
Cardiomyopathy refers to a group of primary diseases affecting the heart muscle, causing it to enlarge, thicken, or become stiffer, which impairs the heart’s ability to effectively pump blood. Early stages may present few symptoms, but as the disease progresses, it can lead to shortness of breath, fatigue, leg swelling, irregular heartbeats, fainting, and an increased risk of sudden cardiac death.
Health Outcomes
- Changed Heart Rate
- Changed QT Interval Length
- Developed Endocarditis
- Developed Polymorphic Ventricular Tachycardia
- Elevated Lactate Levels
- Extended Cardiac Transplant Survival
- Improved CVD-Related Symptom
- Improved Cardiac Function
- Improved Cardiac Histopathology
- Improved Cardiac Muscle Contractile Performance
- Improved Cardiac Muscle Structural Integrity
- Improved Cardiac Output
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Combined Cardiopulmonary Outcomes
- Improved Diastolic Function
- Improved Ejection Fraction
- Improved Exercise Capacity
- Improved Exercise Stress Test Grade
- Improved Exercise Tolerance
- Improved Fractional Shortening
- Improved Hemodynamic Parameter
- Improved Hemodynamic Stability
- Improved Inotropic Function
- Improved Left Ventricular Ejection Fraction
- Improved Left Ventricular Global Longitudinal Strain
- Improved Myocardial Strain
- Improved Myocardial Strain Rate
- Improved Right Ventricular Function
- Improved Stroke Volume
- Improved Systolic Function
- Improved Systolic Myocardial Velocity
- Improved Troponin T Level
- Increased Cross-sectional Area
- Increased Hemodynamic Disturbance
- Increased Organ Weights
- Increased QTc Interval
- Increased Risk of Cardiac Arrhythmias
- Increased Velocity-Time Integral
- Preserved Cardiac Function
- Prolonged Cardiac Allograft Survival
- Prolonged QT Interval
- Reduced Aortic Pressure
- Reduced Cardiac Arrest Risk
- Reduced Cardiac Arrhythmia
- Reduced Cardiac Biochemical Marker
- Reduced Cardiac Damage
- Reduced Cardiac Function
- Reduced Cardiac Hypertrophy
- Reduced Cardiac Output
- Reduced Cardiovascular Dysfunction
- Reduced Coenzyme Q10 Level
- Reduced Coxsackievirus B3 Viral Load
- Reduced Half Relaxation Time
- Reduced Heart Failure
- Reduced Heart Failure Risk
- Reduced Inotropic Support Requirement
- Reduced Intensive Care Unit Mortality
- Reduced Interventricular Septal Thickness in Diastole
- Reduced Iron-Corrected T1
- Reduced Keshan Disease Risk
- Reduced Laminin Level
- Reduced Left Ventricular Ejection Fraction Decline
- Reduced Left Ventricular End-Diastolic Volume
- Reduced Left Ventricular Hypertrophy
- Reduced Maximum Heart Rate
- Reduced Myocardial Injury Cytokines
- Reduced One-Year Arrhythmia
- Reduced Organ Dysfunction
- Reduced Organ Failure Severity
- Reduced Oxygen Consumption during Exercise
- Reduced Palpitation
- Reduced Palpitation Symptoms
- Reduced QRS Interval
- Reduced Stroke Volume
- Reduced Tricuspid Regurgitation
- Reduced Troponin I Level
- Reduced Trypanosoma cruzi Parasitaemia